ADVERTISEMENT

Sun Pharma Q1 Results Review - Limited Upside: Dolat Capital

The brokerage recommends investors to Accumulate the stock on dips.

<div class="paragraphs"><p>File photo (Source: Sun Pharmaceutical Industries/Facebook)</p></div>
File photo (Source: Sun Pharmaceutical Industries/Facebook)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More